Core Viewpoint - Stevanato Group S.p.A. will report its financial results for the fourth quarter and fiscal year 2025 on March 4, 2026, at 6:30 a.m. ET, followed by a conference call at 8:30 a.m. ET to discuss the results [1] Financial Results Announcement - The financial results for the fourth quarter and fiscal year 2025 will be released on March 4, 2026, at 6:30 a.m. ET [1] - A conference call and webcast will be held at 8:30 a.m. ET on the same day to discuss the financial results [1] - Participants are encouraged to pre-register for the conference call to gain immediate access [1] Company Overview - Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries [1] - Founded in 1949, the company offers an integrated portfolio of products, processes, and services that address customer needs across the entire drug life cycle [1] - The company's core capabilities include scientific research and development, technical innovation, and engineering excellence [1]
Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026